skip to page content
Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

2008 HSR&D National Meeting Abstract

National Meeting 2008

1008 — The Association Between Obesity and Charcot Arthropathy in a Diabetic Population

Budiman-Mak E (Center for Management of Complex Chronic Care (CMC3)), Sohn M (CMC3), Stuck RM (Hines VA Hospital), Lee TA (CMC3), Weiss KB (CMC3)

To examine the association of obesity, peripheral neuropathy (PN), and peripheral vascular disease (PVD) with the Charcot arthropathy incidence rate in a large diabetic population.

The Department of Veterans Affairs (VA) inpatient and outpatient administrative datasets were used to identify veterans with diabetes in 2003. Logistic regressions were used to model the likelihood of a veteran developing Charcot arthropathy as a function of individual characteristics, obesity, PN, PVD, diabetic control, and co-morbidities.

Of VA users with diabetes, 652 (0.12%) were newly diagnosed with Charcot arthropathy in 2003. Compared to patients without obesity, PN, or PVD, those with obesity alone were about 57% more likely and those with PN alone were 14 times more likely to develop it. Patients with both obesity and PN were 21 times more likely and those with obesity, PN and PVD were 34 times more likely to develop it. For obese patients with both PN and PVD, a reduction in body mass index by five units was associated with over 0.11% decrease in the absolute risk.

Obesity was significantly associated with increased incidence of Charcot arthropathy, independent of other risk factors. When obesity combines with PN and PVD, its incidence rate increased multiplicatively. Prevention and detection of Charcot arthropathy should take these disease-disease interactions into consideration. Weight reduction is frequently the only modifiable risk factor in this population and can provide a dramatic reduction in the observed incidence of Charcot arthropathy.

VHA primary care physicians can use the results of this study for prevention and early detection of Charcot arthropathy. Patients with unexplained foot and ankle edema will obtain limb protection and vigilant assessment for Charcot arthropathy development. This recommendation is especially critical for obese patients with peripheral neuropathy and PVD. Through increased surveillance of this group with elevated risk, the diabetic population may experience better control of diabetes, a general reduction in the prevalence of Charcot arthropathy, and a reduced rate of amputation for this limb-threatening condition.

Questions about the HSR&D website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.